These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15039438)

  • 1. Proteasomal degradation of N-acetyltransferase 1 is prevented by acetylation of the active site cysteine: a mechanism for the slow acetylator phenotype and substrate-dependent down-regulation.
    Butcher NJ; Arulpragasam A; Minchin RF
    J Biol Chem; 2004 May; 279(21):22131-7. PubMed ID: 15039438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
    Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
    Jefferson FA; Xiao GH; Hein DW
    Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamster.
    Ferguson RJ; Doll MA; Rustan TD; Hein DW
    Pharmacogenetics; 1996 Feb; 6(1):55-66. PubMed ID: 8845861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of Parkinson's disease-associated mutations on stability and folding of DJ-1.
    Görner K; Holtorf E; Odoy S; Nuscher B; Yamamoto A; Regula JT; Beyer K; Haass C; Kahle PJ
    J Biol Chem; 2004 Feb; 279(8):6943-51. PubMed ID: 14607841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid.
    Butcher NJ; Ilett KF; Minchin RF
    Biochem Pharmacol; 2000 Dec; 60(12):1829-36. PubMed ID: 11108798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype of the most common "slow acetylator" arylamine N-acetyltransferase 1 genetic variant (NAT1*14B) is substrate-dependent.
    Millner LM; Doll MA; Cai J; States JC; Hein DW
    Drug Metab Dispos; 2012 Jan; 40(1):198-204. PubMed ID: 22010219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3+ peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype.
    Salazar-González RA; Turiján-Espinoza E; Hein DW; Niño-Moreno PC; Romano-Moreno S; Milán-Segovia RC; Portales-Pérez DP
    Arch Toxicol; 2018 Feb; 92(2):661-668. PubMed ID: 29043425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
    Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
    Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest.
    Hu X; Bryington M; Fisher AB; Liang X; Zhang X; Cui D; Datta I; Zuckerman KS
    J Biol Chem; 2002 May; 277(19):16528-37. PubMed ID: 11864973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli.
    Ferguson RJ; Doll MA; Rustan TD; Baumstark BR; Hein DW
    Pharmacogenetics; 1994 Apr; 4(2):82-90. PubMed ID: 8081415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity.
    Wang D; Para MF; Koletar SL; Sadee W
    Pharmacogenet Genomics; 2011 Oct; 21(10):652-64. PubMed ID: 21878835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1).
    Bruhn C; Brockmöller J; Cascorbi I; Roots I; Borchert HH
    Biochem Pharmacol; 1999 Dec; 58(11):1759-64. PubMed ID: 10571250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyanamide-mediated Inhibition of N-acetyltransferase 1.
    Dierolf D; Scheitza S; Bonifas J; Blömeke B
    Toxicology; 2012 Dec; 302(1):1-10. PubMed ID: 22835378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations.
    Butcher NJ; Ilett KF; Minchin RF
    Pharmacogenetics; 1998 Feb; 8(1):67-72. PubMed ID: 9511183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity.
    Cribb AE; Isbrucker R; Levatte T; Tsui B; Gillespie CT; Renton KW
    Pharmacogenetics; 1994 Jun; 4(3):166-70. PubMed ID: 7920698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic 20S proteasome catalytic subunit propeptides prevent active site inactivation by N-terminal acetylation and promote particle assembly.
    Arendt CS; Hochstrasser M
    EMBO J; 1999 Jul; 18(13):3575-85. PubMed ID: 10393174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center.
    Steinsapir J; Bianco AC; Buettner C; Harney J; Larsen PR
    Endocrinology; 2000 Mar; 141(3):1127-35. PubMed ID: 10698189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.